Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion

Diabetes and Metabolism

Volumn 24, Issue 6, 1998, Pages 544-546

  Meyer, L ^a   Hadjadj, S ^b   Guerci, B ^b   Delbachian, I ^b   Ziegler, O ^b   Drouin, P ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b NONE

Author keywords

Continuous subcutaneous insulin infusion; Diabetes mellitus; Insulin resistance; Lipodystrophy

Indexed keywords

BEZAFIBRATE; CARBUTAMIDE; FENOFIBRATE; HEMOGLOBIN A1C; HUMAN INSULIN; METFORMIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CLINICAL FEATURE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DRUG EFFICACY; FAMILY HISTORY; FEMALE; FETUS DEATH; HUMAN; HYPERLIPOPROTEINEMIA TYPE 4; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; LIPOATROPHIC DIABETES MELLITUS; PREGNANCY COMPLICATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME;

ADOLESCENT; DIABETES MELLITUS, LIPOATROPHIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED;

EID: 0032431839     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Leblanc H, Jadaud JM, Dejax C, et al. Diabète lipoatrophique avec acanthosis nigricans. Normalisation glycémique prolongée par infusion continue d'insuline. Presse Méd, 1984, 13, 987-989.
2. Ursich MJM, et al. Insulin resistance in limb and trunk partial lipodystrophy (type 2 Köbberling-Dunnigan syndrome). Metabolism, 1997, 46, 159-163.
3. Panz VR, Wing JR, Raal FJ, et al., Improved glucose tolerance after lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus : a putative role for Randle's cycle in its pathogenesis? Clinical Endocrinol, 1997, 46, 365-368.
4. Clément K, Basdevant A, Guy-Grand B. Diabète lipoatrophique, une maladie rare de l'adipocyte? Rev Prat, 1994, 44, 1329-1332.
5. Magré J, Reynet C, Capeau J, et al. In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Evidence for heterogeneous postbinding defects. Diabetes, 1988, 37, 421-428.
6. Vigouroux C, Fajas L, Khallouf E, et al. Genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes, 1998, 47, 490-492.